All
RSSArticles
-
When Should a Threatening Patient be Reported?
Recent amendments to federal patient privacy regulations give clinicians new allowance to report patients with mental health issues, but state laws may differ.
-
Report: Proposed Common Rule Revisions Should be Withdrawn
The Notice of Proposed Rulemaking to Revise the Common Rule should be withdrawn, according to a report from the National Academies of Science, Engineering and Medicine.
-
Data On 2,000 Patients Gives Visual of Final Year of Life
Advance planning discussions rarely occur at the time of a life-threatening diagnosis. This, in part, is responsible for the large number of in-hospital deaths depicted by a new visual graphic on the last year of life.
-
Getting Buy-in For Including Cost in Decision-making is Uphill Battle
Any talk of considering costs in treatment decisions usually triggers an immediate outcry against “rationing” of care, experts say.
-
Is Hospital Keeping Spiritual Care Promises In Mission Statement?
Ethicists and chaplains can hold health systems accountable for mission statements referencing “whole person” care and spiritual health.
-
‘Betraying Trust’ of Subjects is Ethical Concern of Unpublished Clinical Trial Data
Ethicists call for research funders to require publication of all completed trials or to make study data publicly available to other investigators.
-
Dietary Supplement Safety
A recent ABC article on a Consumer Reports publication reviewed concerns surrounding dietary supplement safety.
-
Add Fat to the Mediterranean Diet? Some Benefits Found
Studies examining the Mediterranean diet with unrestricted fat intake find benefits on cardiovascular disease, diabetes, and breast cancer risk.
-
Chocolate Counteracts the Effects of Sleep Deprivation
An acute administration of a chocolate rich in flavanols (a subclass of flavonoids) was found to mitigate the cardiovascular and cognitive effects of sleep deprivation in a group of young and healthy individuals.
-
Incretin and Insulin Secretion Improved in Non-Diabetic Individuals by Lactobacillus reuteri Supplementation
In this prospective, double-blind, randomized trial, the probiotic strain Lactobacillus reuteri SD5865 at a dosage of 1010 colony-forming units or placebo was provided to non-diabetic individuals twice daily for a period of four weeks to investigate the effect on various parameters associated with blood sugar handling, including secretion of insulin, C-peptide, and glucagon-like peptides-1 and -2.